April 19, 2022 09:52 ET | Source: PMI PMI
Covina, April 19, 2022 (GLOBE NEWSWIRE) -- Lung cancer starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can potentially spread to the lungs. Metastases are the spread of cancer cells from one organ to another. Small cell and non-small cell lung tumors are the two most common kinds of lung cancer. These kinds of lung cancer grow and respond to treatment in different ways. Non-small cell lung cancer is more prevalent than small cell lung cancer, according to the American Cancer Society. Lung cancer symptoms range from person to person. Symptoms of the lungs affect some persons.
North America dominates the lung cancer diagnostics market, due to rising incidence of lung cancer and the ageing population in the particular region. North America is regarded as the largest regional market with the highest market share due to increased market invasion rates of technologically advanced products, rising patient awareness, and rising smoking prevalence levels in the region are all factors contributing to the region's greatest market share. Due to increased use of lung cancer diagnostics due to rising tobacco smoking in the region, Asia-Pacific (APAC) is predicted to have considerable growth over the projection period.
Request Free Sample Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4863
To know the upcoming trends and insights prevalent in this market, click the link below:
Links- https://www.prophecymarketinsights.com/market_insight/Global-Lung-Cancer-Diagnostic-Test-Market-4863
Global Lung Cancer Diagnostic Test Market accounted for US$ 1.98 billion in 2020 and is estimated to be US$ 4.07 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global Lung Cancer Diagnostic Test Market is segmented by Test Type, Cancer Type, End-Use Industry and Region.
The key players operating in the Global Lung Cancer Diagnostic Test Market includes Abbott, Illumina, Inc., Thermo Fischer Scientific, QIAGEN, Quest Diagnostics Incorporated, NeoGenomics, NanoString, Myriad Genetics Inc., F. Hoffmann-La Roche Ltd, Danaher, Agilent Technologies, Inc., AstraZeneca, Sanofi, and Janssen Pharmaceuticals, Inc.
For Customization: https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/4863
Prophecy Market Insights is market research, analysis, marketing/business strategy and customized solutions that provide strategic and tactical support to clients to make informed business decisions and identify and achieve high value opportunities in target business areas. We also help our clients solve business challenges and provide the best solutions to overcome them and transform their business. Following are some of the key points answered in this market report: